Citations

Clear

9 citation(s) found for "Soin, A G".

Representation of Women in Atrial Fibrillation Clinical Trials: A Systematic Review
Ibrahim, Ramzi, Pham, Hoang Nhat, Kanaan, Christopher , Alhwarat, Buthainah, Sainbayar, Enkhtsogt , Soin, Sabrina , Ayoub, Chadi, Chieffo, Alaide , Sharma, Garima , Protheroe, Jo , Lee, JC, Arsanjani, Reza, Mamas, Mamas A., Sharma, Garima , Pham, Hoang Nhat , Ibrahim, Ramzi , Ibrahim, Ramzi , Nhat, Hoang , Ayoub, Chadi , Deshmukh, Abhishek J , Arsanjani, Reza , Lee, Kwan S , Mamas, Mamas , Sharma, Garima , Kanaan, Christopher N , Ibrahim, Ramzi , Arsanjani, Reza , Lee, Kwan , Mamas, Mamas A.

Mayo Clinic

Reviews in Cardiovascular Medicine | March 31, 2026 | Volume: 27 | Issue: 3 | Pages: No page available

10.31083/rcm47907 | PMID 41923740 Get It

Background: Disparities exist in the representation of genders in cardiovascular clinical trials. Atrial fibrillation (AF) is associated with significant morbidity and mortality; however, understanding regarding the representation of women in AF-related clinical trials remains limited. Therefore, this systematic review sought to evaluate the representation of women in AF-related clinical trials. Methods: We conducted a systematic review of clinical trials using the PubMed, Scopus, and EMBASE databases from 1996 to January 1st, 2024, focusing on AF-related lifestyle interventions, pharmacological treatments, catheter ablation, and device therapies for AF. Data extraction and analysis encompassed trial characteristics, participant demographics, and funding sources. The primary outcome was the prevalence of female enrollees, quantified through participation-to-prevalence ratios (PPRs). This was estimated overall and stratified by funding source, intervention type, and enrollment region. Results: Of the 103 clinical trials involving 218,322 participants (39.5% female), the PPR ranged from 0.00 to 1.73, with an average PPR of 1.03. Meanwhile, 43% of the trials exhibited female under-representation (PPR, <0.8). University-funded trials showed higher female enrollment (mean PPR, 0.951) compared to industry/government-funded trials (mean PPR, 0.800). No differences were observed in the representation of women when comparing enrollment regions or intervention types. Conclusions: Despite advancements in AF management, gender disparities persist in AF-related clinical trial representation, particularly in industry/government-funded studies compared to university-funded trials. Thus, addressing implicit biases and enforcing sex equality guidelines are critical steps toward more inclusive cardiovascular research.
Living liver donor safety: Intraoperative considerations in living liver donation—Guidelines from the ILTS–iLDLT group consensus conference 2025
Bhangui, Prashant , Hakeem, Abdul Rahman , Maira, Tommaso Di , Rammohan, Ashwin, Sayed, Blayne A. , Soejima, Yuji , Shingina, Alexandra , Cheah, Yee Lee , McCluskey, Stuart, Spiro, Michael , Ganesh, Swaytha , Rajalingam, Rajesh , Gupta, Subash , Findlay, James Y. , Chieh, Alfred Kow Wei, Sakamoto, Seisuko, Xia, Qiang, Kim, Ki-Hun , Polak, W., Soin, A G, Pomposelli, James J. , Vyas, Mary, Wiggins, Chantal, Mas, Valeria, Taner, Timucin, Broering, Dieter, Chen, Chao-Leng, Burra, Patrizia, Ascher, N. L., Lerut, Jan, Rela, Mohamed, Selzner, Nazia, Balci, Deniz, Olthoff, Kim M. , Polak, Wojciech G. , Hakeem, Abdul , Rammohan, Ashwin , Sayed, Blayne A , McCluskey, Stuart , Findlay, James, Sakamoto, Seisuko , Xia, Qiang , Polak, Wojciech G , Sapisochin, Gonzalo , Pomposelli, James , Selzner, Nazia , Balci, Deniz , Bhangui, Prashant , Di Maira, Tommaso , Gupta, Amar C. , Xia, Qiang , Sapisochín, Gonzalo , Soin, Arvinder S., Taner, Timuçin , Bröering, Dieter C. , Terrault, Norah A. , Burra, Patrizia , Hirschfield, Gideon M. , Lerut, Jan , Rela, Mohamed , Heimbach, Julie K. , Selzner, Nazia

Mayo Clinic

Liver Transplantation | January 5, 2026 | Volume: 32 | Issue: 4 | Pages: 592-608

10.1097/lvt.0000000000000800 | PMID 41490582 Get It

The success of living donor liver transplantation (LDLT) has bridged the growing gap between organ demand and availability in patients with liver failure or liver cancer. Safety of the living liver donor (LLD) is paramount, and astute intraoperative management plays a critical role in ensuring optimal outcomes for them. Given that intraoperative surgical and anesthesia practices vary widely across centers, the International Liver Transplantation Society (ILTS) and the International Living Donor Liver Transplantation Group (iLDLT Group) convened a global consensus conference in Toronto in March 2025 to develop guidelines for intraoperative management of the LLD. This manuscript details the recommendations on intraoperative considerations for the safety of LLD developed by Working Group II of the Consensus Scientific Committee, using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system for assessment of recommendations, and the Danish model of consensus. Working Group II focused on intraoperative monitoring, fluid and ventilation strategies, surgical techniques for vascular and biliary division, surgeon and center-specific experience, and intraoperative crises planning. These guidelines aim to support both established and emerging LDLT teams to ensure high-quality and safe intraoperative care for the LLD.
Transbronchial cryobiopsy to diagnose diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH)
Chand, Arista , Filsoof, Darius, Manchen, Peter , Soin, Sabrina, Soin, Sabrina

Mayo Clinic

BMJ Case Reports | July 17, 2025 | Volume: 18 | Issue: 7 | Pages: e266666

10.1136/bcr-2025-266666 | PMID 40675655 Get It

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare precursor of neuroendocrine malignancy. Diagnosis is difficult as clinical and radiological findings can be non-specific. Histological confirmation is necessary, and surgical lung biopsy is still considered the gold standard technique to aid multidisciplinary discussion. There are increasing reports of using transbronchial lung cryobiopsy (TBLC) for tissue sampling, allowing a feasible and safe alternative to diagnosis. Here we present a case of cough, dyspnoea and hypoxia in a woman ultimately diagnosed with DIPNECH using TBLC.
New Onset Atrial Fibrillation in Chronic Obstructive Pulmonary Disease, Obstructive Sleep Apnea, and Overlap Syndrome: A Retrospective Observational Study from the Trinetx Database
Hoffer, M., Kanaan, Camille, Soin, S., Pham, H.N., Adkins, Arlie , Kanaan, C., Mahmoud, M., Ibrahim, R.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A5315-A5315

10.1164/ajrccm.2025.211.abstracts.a5315 Get It

Abstract RATIONALE:New-onset atrial fibrillation (NOAF) is a common arrhythmia associated with adverse outcomes in patients with chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA). Both conditions, through shared mechanisms, raise the likelihood of NOAF incidence, emphasizing the importance of epidemiological data and preventive measures to prevent NOAF burden. Therefore, we examined the risk of NOAF in patients with COPD, OSA, and their overlap syndrome (OS). METHODS: We extracted data from the Banner Healthcare Organization, US Collaborative Network in TriNetX, identifying three patient cohorts using ICD-10 codes for COPD (J40-J44) and OSA (G47.3). This included 73,540 patients with OS, 198,880 patients with OSA only, and 337,010 patients with COPD only. Patients with a prior diagnosis of AF before their diagnosis of OSA or COPD were excluded. Propensity matching was conducted based on age, sex, ethnicity, and cardiovascular disease risk factors and prevalence including hypertension, tobacco use, dyslipidemia, obesity, and ischemic heart disease. We calculated the relative risk (RR), hazard ratio (HR), and 95% confidence intervals (CI) for incident AF among propensity score-matched cohorts, comparing OS with OSA alone and OS with COPD alone.RESULTS: In the OS vs. OSA only comparison, 63,070 patients were matched per cohort. Lifetime incidence of new AF was higher in the OS group (13.65%) compared to the OSA-only group (8.24%), with an RR of 1.66 [95% CI: 1.60-1.72]. Kaplan-Meier analysis indicated a lower AF-free probability in the OS group (65.96%) than in the OSA-only group (77.03%), with an HR of 1.56 (p &lt; 0.001). In the OS vs. COPD only comparison, 65,810 patients were matched per cohort. Incidence of new AF in the OS group was 13.76%, compared to 9.86% in the COPD-only group, with an RR of 1.40 [95% CI: 1.35-1.44]. Kaplan-Meier analysis showed a lower AF-free probability for the OS group (66.13%) versus the COPD-only group (78.94%), with an HR of 1.28 (p &lt; 0.001). Sensitivity analyses restricted to the first five years post-diagnosis revealed a persistently higher relative risk of incident AF in OS patients, with an RR of 1.67 [95% CI: 1.60-1.73] compared to OSA alone, and an RR of 1.34 [95% CI: 1.29-1.39] compared to COPD alone. CONCLUSION:We identified that patients with OS have a higher risk of NOAF compared to either condition alone. This emphasizes the need for vigilant monitoring and targeted interventions in patients with OS to decrease arrhythmogenicity risks.
Pulmonary Embolism Mortality Trends and Disparities in Patients With Cancer in the United States, 1999 – 2020
Marco, Teresa Navío, Hoffer, Mariëtte J.V. , Ritter, Julia, Sumner, Richard E., Ibrahim, Radwa, Ritter, John , Soin, S., Pham, H.N., Marco, T., Hoffer, M., Sumner, R., Ibrahim, R.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A2842-A2842

10.1164/ajrccm.2025.211.abstracts.a2842 Get It

Abstract RATIONALE: The diagnosis of Pulmonary Embolism (PE) is associated with high mortality and morbidity. In patients with cancer, high-risk pulmonary emboli further escalate these risks. Ensuring access to the necessary resources for appropriate intervention is crucial for improving patient outcomes. However, the resource-intensive nature of managing multiple life-threatening conditions can create barriers for certain demographic populations, leading to disparities in outcomes. To address this issue, we explored mortality trends among diverse groups based on gender, ethnicity, and geographical background in the United States from 1999-2000. METHODS: We obtained mortality data from death certificate queries in the Centers for Disease Control and Prevention Wide-range Online Data for Epidemiologic Research database. Queries included all decedents with the underlying cause of death being PE (I26) in patients with a diagnosis of cancer (C00 – C97). Age-adjusted mortality rates (AAMR) per 100,000 people were compared across demographic populations, and 95% Confidence Intervals were standardized to the year 2000. Log-linear regression models were utilized to assess temporal mortality shifts and calculate annual percentage change (APC) from 1999 to 2020. RESULTS: A total of 179483 PE-related deaths was reported in patients with cancer. The AAMR increased from 2.14 [2.08-2.19] in 1999 to 3.05 [3.00-3.11] in 2020. The cumulative AAMR was 2.42 [2.41-2.43] with an average APC of +1.56% (p&lt;0.001). The mortality rate accelerated following the year 2016, with the years prior having an APC of +0.69%, (p&lt;0.001) and the years following having an APC +5.33% (p&lt;0.001). A higher mortality was observed in males (AAMR 2.71 [2.69-2.73]) than females (2.20 [2.18-2.21]), in rural communities (AAMR 2.50 [2.47-2.53]) compared to urban communities (AAMR 2.38 [2.37-2.40]), and in non-Hispanic (AAMR 2.48 [2.47-2.49]) populations over Hispanic populations (AAMR 1.45 [1.42-1.48]). Mortality was highest in the Black population (AAMR 3.65 [3.60-3.69]), followed by White population (AAMR 2.33 [2.32-2.34]), American Natives (AAMR 1.43 [1.33-1.54]), and Asian (AAMR 1.04 [1.00-1.08]). Geographically, Midwest (AAMR 2.58 [2.56-2.61]) had the highest mortality while the South (AAMR 2.26 [2.24-2.28]) had the lowest mortality. CONCLUSIONS: We identified significant disparities in mortality related to pulmonary embolism (PE) among cancer patients across different demographic populations. Further investigation into these healthcare inequities is essential for addressing the disparities affecting various groups.
Preventing Small-for-size Syndrome in Living Donor Liver Transplantation: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference
Aunés, Carmen Vinaixa, Mazzola, Alessandra , Alconchel, Felipe , Yoon, Young-In, Testa, Giuliano , Soin, Arvinder S., Pomposelli, James J. , Menon, Krishna , Kota, Venugopal, Abu‐Gazala, Samir , Rodríguez-Dávalos, Manuel I. , Rajalingam, Rajesh , Kapoor, Dharmesh, Kamath, Patrick S. , Sudhindran, Surendran, Vij, Vivek , Egawa, Hiroto , Lerut, Jan , Bröering, Dieter C. , Berenguer, Marina , Cattral, Mark S. , Clavien, Pierre‐Alain , Chen, Chao‐Long, Shah, Samir, Zhu, Zhi‐Jun , Ascher, Nancy L. , Emond, Jean C. , Rela, Mohamed , Kamath, Patrick, Berenguer, Marina , Alconchel, Felipe , Hakeem, Abdul , Mathew, Johns Shaji , Yoon, Young-In, Selzner, Nazia , Sarin, Shiv Kumar , Lee, Kwang‐Woong , Goyal, Neerav , Durand, François , Jothimani, Dinesh , Sudhindran, Surendran, Yoshizumi, Tomoharu , Bhangui, Prashant , Rammohan, Ashwin

Mayo Clinic

Transplantation | August 28, 2023 | Volume: 107 | Issue: 10 | Pages: 2203-2215

10.1097/tp.0000000000004769 | PMID 37635285 Get It

Small-for-size syndrome (SFSS) is a well-recognized complication following liver transplantation (LT), with up to 20% developing this following living donor LT (LDLT). Preventing SFSS involves consideration of factors before the surgical procedure, including donor and recipient selection, and factors during the surgical procedure, including adequate outflow reconstruction, graft portal inflow modulation, and management of portosystemic shunts. International Liver Transplantation Society, International Living Donor Liver Transplantation Group, and Liver Transplant Society of India Consensus Conference was convened in January 2023 to develop recommendations for the prediction and management of SFSS in LDLT. The format of the conference was based on the Grading of Recommendations, Assessment, Development, and Evaluation system. International experts in this field were allocated to 4 working groups (diagnosis, prevention, anesthesia, and critical care considerations, and management of established SFSS). The working groups prepared evidence-based recommendations to answer-specific questions considering the currently available literature. The working group members, independent panel, and conference attendees served as jury to edit and confirm the final recommendations presented at the end of the conference by each working group separately. This report presents the final statements and evidence-based recommendations provided by working group 2 that can be implemented to prevent SFSS in LDLT patients.
Paging the Clinical Informatics Community: Respond STAT to Dobbs v. Jackson's Women's Health Organization
Ravi, Akshay , Weia, Benjamin , Aarts, Jos , Ahmad, Hasan B., Araj, Ellen, Bauml, Julie A., Boyd, Andrew D. , Brecht-Doscher, Aimee, Butler‐Henderson, Kerryn , Butte, Atul J. , Cardilo, Anthony B., Chilukuri, Nymisha , Cho, Mildred K. , Cohen, Jenny K., Craven, Catherine K. , Crusco, Salvatore, Dadabhoy, Farah Z. , Dash, Dev , DeBolt, Claire , Fayanju, Oluseyi A, Fochtmann, Laura J. , Graham, Justin V., Hanna, John , Hofford, Mackenzie , Hron, Jonathan D. , Huang, Sean S, Jackson, Brian R. , Kaplan, Bonnie , Kelly, William R. , Ko, Kyungmin, Kurapati, Nikhil , Labbad, Gabriel , Lee, Julie , Leitner, Stefano, Liao, Zachary C , Melnick, Edward R. , Muniyappa, Anoop , Murray, Sara G. , Nichols-Johnson, Victoria, Novak, Laurie L. , Ogan, William Scott , Ozeran, Larry, Pageler, Natalie M. , Pandita, Deepti , Perumbeti, Ajay, Petersen, Carolyn , Pierce, Logan , Puttagunta, Raghuveer, Ramaswamy, Priya , Rogers, Kendall, Ryan, Angela M., Sarabu, Chethan , Shaw, Kate A. , Spector, Jacob D. , Starren, Justin , Stoffel, Michelle , Swanson, Karl , Tomes, Adrian, Unertl, Kim M. , Weon, Jenny L. , Wiley, Kevin , Winkelstein, Peter , Wong, Jenson, Xie, James , Yarahuan, Julia , Yung, Nathan , Zera, Chloe , Sadasivaiah, Shobha , Boyd, Andrew D , Melnick, Edward R , Petersen, Carolyn , Arvisais‐Anhalt, Simone , Benham‐Hutchins, Marge , Brecht-Doscher, Aimee, Elkin, Peter L. , Hersh, William , Kelly, William, Koppel, Ross , Lehmann, Christoph U. , Medford, Richard J , Neinstein, Aaron Barak , Rosenbloom, S. Trent , Ryan, Angela, Saleh, Sameh Nagui , Schreiber, Richard , Sim, Ida , Sirintrapun, Sahussapont Joseph , Solomonides, Anthony , Subbian, Vignesh , Trang, Karen , Whooley, Mary A. , Williamson, Drew F. K. , Ratanawongsa, Neda

Mayo Clinic

Applied Clinical Informatics | December 19, 2022 | Volume: 14 | Issue: 01 | Pages: 164-171

10.1055/a-2000-7590 | PMID 36535703 Get It

Response to: Invasive Treatments for Low Back Disorders and the ACOEM Practice Guidelines
Sayeed, Yusef, Chang, Richard G., Chhatre, Akhil, Vallabh, Jayesh, Soin, Amol, Mauck, William D., Duszynski, Belinda S., Kreiner, D. Scott, Sayeed, Yusef, Chang, Richard G., Chhatre, Akhil, Vallabh, Jayesh, Soin, Amol, Mauck, William D., Duszynski, Belinda S., Kreiner, D. Scott

Mayo Clinic

Journal of Occupational & Environmental Medicine | December 7, 2021 | Volume: 64 | Issue: 2 | Pages: e81-e83

10.1097/jom.0000000000002454 | PMID 34873134 Get It